Chief Scientific Officer · MYRIAD GENETICS INC (MYGN)

Jerry Lanchbury

A named executive officer of MYRIAD GENETICS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,829,238

Salary $493,496Stock awards $1,197,200

FY2019: $2,685,750

7th of 8 named executive officers at Myriad Genetics by FY2020 total.

8 named officers on file for MYRIAD GENETICS, FY2020

Jerry Lanchbury’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • MYGN’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MYRIAD GENETICS’s whole pay program stands against its peers

  • MYRIAD GENETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MYGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 15, 2020 (DEF 14A).

Free

Get Jerry Lanchbury’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jerry Lanchbury compensation by year

MYRIAD GENETICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as MYRIAD GENETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$479,400$493,782$493,782$508,595$493,496
Bonus$512$307$0$200$0
Stock awards$1,986,563$1,095,000$1,628,500$1,914,000$1,197,200
Option awards$0$0$0$0$0
Non-equity incentive$215,730$214,795$244,422$250,228$131,599
Pension and deferred compensation$0$0$0$0$0
All other$11,297$10,960$10,972$12,727$6,943
Total$2,693,502$1,814,844$2,377,676$2,685,750$1,829,238

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MYRIAD GENETICS INC DEF 14A filed October 15, 2020, accession 0001193125-20-269774, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MYRIAD GENETICS INC filed document, accession 0001193125-20-269774. Every figure is read from that document and cited to the page and table it appears in. Filed October 15, 2020.

$2.7M
$1.8M
$2.4M
$2.7M
$1.8M
FY16
FY17
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU39,196$774,905—
PSU39,195$774,885—
RSU24,600$486,342—
RSU19,000$375,630—
RSU12,500$247,125—
RSU10,068$199,044—

Per the Outstanding Equity Awards at Fiscal Year-End table in MYRIAD GENETICS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

MYRIAD GENETICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Paul DiazPresident and Chief Executive Officer$15,500,821
Mark CaponeFormer President and Chief Executive Officer and Director$6,174,458
R. Bryan RiggsbeeChief Financial Officer and Treasurer; Interim President and Chief Executive Officer$4,203,341
Alexander FordFormer Chief Operating Officer$2,183,043
Gary KingFormer Executive Vice President International Operations$1,961,159
Bernard TobinFormer President of Myriad Autoimmune$1,879,045
Jerry Lanchbury · this pageChief Scientific Officer$1,829,238
Nicole LambertWomen’s Health, Oncology, and International$1,704,706

The full MYRIAD GENETICS compensation record

free company brief

This page is one person within MYRIAD GENETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MYRIAD GENETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MYRIAD GENETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jerry Lanchbury's compensation dossier · One-time report. No refunds.